Glaucoma Pharmacotherapy: Implications for Flying Fitness
Abstract:Lam PM. Glaucoma pharmacotherapy: implications for flying fitness. Aviat Space Environ Med 2005; 76:786–93.
The objective of lowering the intraocular pressures remains the mainstay of therapy in the management of glaucoma, and may be achieved by medication, laser, or surgery. For many years the pharmacotherapy available, while quite effective, were few in number; principally timolol, pilocarpine, and oral acetazolamide. Through extensive research in glaucoma treatment, ophthalmologists now have access to a dozen different medications to treat glaucoma. This has invariably led to a decrease in the need for laser or surgery to control the intraocular pressures, and the number of glaucoma operations performed has progressively declined over the past few years. However, aviation medicine practitioners need to be aware of the potential adverse effects of these medications as some of these undesirable side effects may render the drugs unsuitable for aircrew.
Document Type: Research Article
Publication date: 2005-08-01
More about this publication?
- The peer-reviewed monthly journal, Aviation, Space, and Environmental Medicine (ASEM) provides contact with physicians, life scientists, bioengineers, and medical specialists working in both basic medical research and in its clinical applications. It is the most used and cited journal in its field. ASEM is distributed to more than 80 nations.
To access volumes 86 to present, please click here.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Submit Articles
- Ingenta Connect is not responsible for the content or availability of external websites